OpenEvidenceReported
Apple launches a health AI study app built with OpenEvidence, seeking up to 200,000 US iPhone users.
Apple Unveils OpenEvidence: Pioneering Health AI Research
Cupertino, CA – November 16, 2026 – Apple today announced the launch of OpenEvidence, a groundbreaking new health application designed to accelerate artificial intelligence research in the medical field. The app, available exclusively on iOS, marks a significant step in Apple’s commitment to health innovation, inviting up to 200,000 US iPhone users to participate in this ambitious study.
The launch
The OpenEvidence app officially debuted today, November 16, 2026, making it accessible to a select group of iPhone users across the United States. This strategic launch aims to gather a substantial dataset, crucial for the development and refinement of next-generation health AI technologies. Apple’s entry into this specific niche of health research underscores its long-term vision for integrating advanced AI capabilities into personal health management.
What OpenEvidence does
OpenEvidence is built as a health AI study application, directly engaging users in the data collection process. While specific features are designed to be intuitive and user-friendly, the core functionality revolves around contributing anonymous health-related data to a secure, privacy-focused research platform. This data will then be utilized by researchers to train and validate artificial intelligence models, ultimately leading to more accurate diagnoses, personalized treatments, and predictive health insights. The app is meticulously designed to ensure user privacy and data security are paramount, adhering to Apple’s stringent standards.
Why it matters
The introduction of OpenEvidence holds immense potential for the future of healthcare. By enlisting a large cohort of iPhone users, Apple is creating an unprecedented opportunity to gather diverse and real-world health data at scale. This collaborative approach between technology and health research could significantly accelerate breakthroughs in medical AI, potentially leading to earlier disease detection, more effective interventions, and a more proactive approach to personal well-being. The success of OpenEvidence could pave the way for a new paradigm in health research, where individuals actively contribute to the advancement of medical science through their everyday devices.